×
For best experience we recommend to activate Javascript in your browser.
MAP1A antibody (AA 2552-2759)
The Rabbit Polyclonal anti-MAP1A antibody has been validated for IHC, IP, WB and ICC. It is suitable to detect MAP1A in samples from Mouse.
Quick Overview for MAP1A antibody (AA 2552-2759) (ABIN7622474)
Target
See all MAP1A Antibodies
MAP1A
(Microtubule-Associated Protein 1A (MAP1A))
Reactivity
All reactivities for MAP1A antibodies
Mouse
Host
All hosts for MAP1A antibodies
Rabbit
Clonality
All clonalities for MAP1A antibodies
Polyclonal
Conjugate
All conjugates for MAP1A antibodies
This MAP1A antibody is un-conjugated
Application
All applications for MAP1A antibodies
Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Immunocytochemistry (ICC)
Product Details anti-MAP1A Antibody
(hide)
Binding Specificity
All epitopes for MAP1A antibodies
AA 2552-2759
Purpose
Microtubule Associated Protein 1A (MAP1A) Polyclonal Antibody
Sequence
Asp2552~Ser2759
Characteristics
The Microtubule Associated Protein 1A (MAP1A) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.2 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for MAP1A
(hide)
Target
MAP1A
(Microtubule-Associated Protein 1A (MAP1A))
Alternative Name
MAP1A
Gene ID
17754
UniProt
Q9QYR6
Pathways
Microtubule Dynamics , Sensory Perception of Sound
Recently viewed
(hide)
Chat with us , powered by LiveChat